Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca Tasting Nektar
Yahoo/Zacks.com
Tuesday, September 22, 2009 - 7:39pm
tags:
AstraZeneca, Nektar, Abbott Laboratories, licensing
Good News for Top of AMGN's Pipeline
Yahoo/Zacks.com
Tuesday, September 22, 2009 - 7:38pm
tags:
Amgen, GSK, Novartis, denosumab
Who's the greenest pharma of all?
Fierce Pharma
Tuesday, September 22, 2009 - 11:42am
tags:
pharma industry, environmental concerns
The Jury's Out On Dendreon
CNBC
Tuesday, September 22, 2009 - 11:40am
tags:
Dendreon
FDA to review CombinatoRx drug application
Bizjournals.com
Tuesday, September 22, 2009 - 10:44am
tags:
FDA, CombinatoRx, Exalgo
FDA says it confirmed new cases of brain inflammation linked to MS drug, bringing total to 13
Yahoo/AP
Tuesday, September 22, 2009 - 10:43am
tags:
FDA, PML, Tysabri, MS, Biogen Idec, Elan
Abbott says study shows its Xience V stent was more effective than Boston Scientific's Taxus
Yahoo/AP
Tuesday, September 22, 2009 - 10:42am
tags:
Abbott Laboratories, stents, Xience, Boston Scientific, Taxus
BioCryst Steps Closer to Emergency Application
Yahoo/Indie Research
Tuesday, September 22, 2009 - 9:45am
tags:
Biocryst, peramivir, H1N1, Flu
A bitter pill for Pfizer retirees
The Day, CT
Tuesday, September 22, 2009 - 9:20am
tags:
Pfizer, retirement
Cell Thera Tries Bait-and-Switch With Opaxio
TheStreet.com
Tuesday, September 22, 2009 - 9:18am
tags:
Opaxio, Cell Therapeutics, lung cancer
Oxford Bio's failed cancer vaccine may help some
Reuters
Tuesday, September 22, 2009 - 9:16am
tags:
Oxford BioMedica, vaccines, cancer
Buying binge hits biotech firms
Boston Globe, MA
Tuesday, September 22, 2009 - 9:03am
tags:
biotech, Facet Biotech, M&A, Biogen Idec, Inverness Medical, Sepracor
Facet advises 'no action' on Biogen bid
Bizjournals.com
Tuesday, September 22, 2009 - 8:48am
tags:
Facet Biotech, Biogen Idec, M&A
Valeant Works On Base After Price Pullback
Yahoo/Investors Business Daily
Tuesday, September 22, 2009 - 8:39am
tags:
Valeant Pharmaceuticals
Glaxo Could Find Reasons to Extend Its Alliance with Dr. Reddy's
Seeking Alpha
Tuesday, September 22, 2009 - 8:34am
tags:
GSK, Dr Reddy's, partnerships
Pfizer, Wyeth selling animal health assets to Boehringer as they try to close buyout deal
Yahoo/AP
Monday, September 21, 2009 - 6:31pm
tags:
Pfizer, Wyeth, Boehringer Ingelheim, veterinary medicine, animal health
Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful
BNET Pharma
Monday, September 21, 2009 - 5:23pm
tags:
Effient, Onglyza, diabetes, Eli Lilly, AstraZeneca, Bristol-Myers Squibb
Lilly Reaches Zyprexa Agreement With Seven States
Bloomberg
Monday, September 21, 2009 - 5:18pm
tags:
Eli Lilly, Zyprexa, settlements
Inhibitex Initiated at Neutral with Significant Upside Potential
Seeking Alpha
Monday, September 21, 2009 - 4:52pm
tags:
Inhibitex, pipelines
Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
Yahoo
Monday, September 21, 2009 - 4:50pm
tags:
Adolor, liscensing, OpRA III, Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.